Examination of Mechanisms Involved in Spasticity Reduction after BTX-A Injection in Hemiplegic Patients

Document Type : Research Paper

Authors

Abstract

I





ntroduction: Spasticity is a common and disabling complication that occurs as a result of upper motor neuron lesion. Recently, Botulinum Toxin – A (BTX-A) has received a pronounced position in spasticity treatment because of its efficacy, high capability of selective effects and low side effects. In this study, through electrophysiologic tests, mechanisms involved in spasticity reduction following BTX-A injection were studied.
Materials and Methods: This descriptive study was carried out in the year 2006, on 15 hemiplegic patients (age ranged 44- 70 yrs) with spasticity of ankle plantar flexors at Tehran University of medical Sciences. According to the Original Ashworth Scale (OAS), before and after intervention, spasticity of muscles was assessed. Electrophysiologic measurements consisted of amplitude of maximum H- reflex, M response and H / M ratio of soleus muscle, were recorded before and after injection. Toxin was injected in Gastrocnemius (200 units), soleus (75 units) and posterior tibialis muscles (50 unit). Data were recorded in a questionnaire and analyzed by descriptive statistics and frequency distribution tables.
Results: Four weeks after injection, significant reduction in H- reflex, M response amplitudes and H / M ratio were seen. According to the OAS, severity of spasticity also, showed a meaningful reduction. H – Reflex amplitude had more expressive reduction than M response.
Conclusion: Reduction of H -reflex amplitude and H / M ratio is the result of toxin effect on intrafusal fibers and reduction of M response amplitude is the result of toxin effect on extrafusal fibers. More significant reduction of H – reflex amplitude in comparison to M response, showed that BTX-A can reduce the spasticity through modification of gamma motor neuron system. Results of this study could help the therapists, in selecting the most efficient therapeutic exercises, for application after the BTX-A injection.

Keywords

References

1- Lance JW. Symposium Synopsis. In: Infeldman RG, Young RR, Koella WP. Spasticity:Disordered Motor
Control. Chicago: Year Book Medical Publishers; 1980.
2- Nathaniel H, Mayer. Clinicophysiologic concepts of spasticity and motor dysfunction in adults with an upper
motor neuron lesion. Muscle & nerve 1997; 6(Supple.): 1-11.
3- Elovic EP, Simone KL, Zafonte R. Outcome assessment for spasticity management in the patients with traumatic
brain injury. Head trauma Rehabil, 2004; 19(2): 155-77.
4- Bobath B. Adult hemiplegia, evaluation and treatment. 2nd Edition.London: William Heinemann Medical book
Ltd; 1991.
5- Mitchell f Brin. Botulinum toxin: chemistry, pharmacology, Tixicity and Immunology. Muscle & nerve, 1997;
6(suppl.): 159.
6- Aoki KR. Pharmacology and immunology of BTX-A. clin Dermatol. 2003; 21(6): 476-80.
7- Bhidayasiri R, Troung OD. Expanding use of botulinum toxin. J Neurol Sci 2005; (1-2):1-9.
8- Raymond A, Arimura K, Trakenaga S. Extrafusal and intrafusal muscle effects in experimental BTX-A
injections. Muscle & Nerve 1996; 19: 488-96.
9- Yagiz on A, Kirazli Y, Kismali B. Mechanisms of action of phenol block and BTX-A in relieving spasticity
.Muscle & Nerve 1999; 78(4): 344-49.
10- Stampacchia G, Bradaschia E. Change of stretch reflex threshold in spasticity: Effect of BTX- A injections.
Arch Ital Biol 2004; 142(3): 263-73.
11- Albany K. Physical and occupational theraphy considerations in adult patients receiving botulinum toxin
injections for spasticity. Muscle & Nerve 1997; Supplement 6: 221-229.
12- Bohannon R, Smith MB. Interrater reliability of a modified ashworth scale of muscle spasticity. Physiotherapy
1987; 67(2):20-21.
13- Kimura J. Electrodiagnosis in disease of nerve and muscle, Principles and practice. 2nd edition. F.A Davis
Company; 1989. 356-368.
14- Brin F. Dosing administration and atreatment algorithm for use of BTX-A for adult-onset spasticity. Muscle &
nerve 1997; 6(Suppl.): 206-220.
15- Funase K, Higashi T, Yoshimura. Evident difference in the excitability of the motoneuron pool between normal
subjects and patients with spasticity assessed by a new method using H- reflex and M –response. Neuroscience
Letters 1996; 203:127-130.
16- Lefaucheur JP. Electrophysiological Assessment of reflex pathway involved in spasticity. Neurochirugie 2003;
49(2-3pt2): 205-14.
17- Pauri F, Boffa L, Cassette E. Btx-A treatment in spastic paraparesis: a neurophysiological study. J Neurol Sci
2000; 181: 89-97.
18- Koman LA, Mooney JF, Smith BP. Neuromuscular Blockage in the treatment of lower extremity spasticity in
cerebral palsy. J pediatr Orthop 2000; 20(1): 108-15.
19- Richardson D, Sheen G, Werring D. Evaluating the role of botulinum toxin in the management of focal
hypertoniain adults. J Neurol Neurosurg Psychiatry 2000; 69(4): 499-506.
20- Lagalla G, Danni M, Reiter F. Post stroke spasticity management with repeated botulinum toxin injections in the
upper limb. Am J Phys Med Rehabil 2000; 79 (4): 377- 84. 
21- Gormely Jr, Obrein F, Yablin S. A clinical overview of treatment decision in the management of spasticity.
Muscle & nerve 1997; 6(suppl.):14-30.
22- Graham HK , Aoki KR, Autti I, Boyd RN, Delgado MR, Gormley ME. Recommendations for the use of
botulinum toxin type A in the management of cerebral palsy. Gait and Posture 2000; 1: 67-79.
23- Leach J. hildren undergoing treatment with botulinum toxin: The role of the physical therapist. Muscle & Nerve
1997; Supplement 6: 194-204.
24- Suputtitada A. Managing spasticity in pediatric cerebral palsy using a very low dose of botulinum toxin type A.
Am-J-Phys-Med-Rehabil 2000; 79(2):11-14.
25- Lim EC, Ong BK, Seet RC. Botulinum toxin – A injections for spastic toe clawing .Parkinsonism related Disord
2006; 12(1):43-7.
26- Pidcock FS. The emerging role of therapeutic BTX-A in the treatment of cerebral palsy. J pediatr 2004; 145 (2
Suppl): 33-5.
27- Russman BS, Tilton A, Gormley M. Cerbral palsy: A rational approach to a treatment protocol, and the role of
botulinum toxin in treatment. Muscle & Nerve 1997; Supplement 6: 181-190. 
medical journal of mashhad university of medical sciences
Volume 50, Issue 3 - Serial Number 3
September and October 2007
Pages 301-308

Files

Share

How to cite

Statistics